Open Access Short Communication Article ID: OJA-4-113

    Barriers and solutions to stepping down asthma treatment

    Nguyen-Ho Lam*

    Asthma is a chronic airway disease with two characteristic features: (1) chronic airway inflammation (the most common eosinophilic airway inflammation) and (2) airway hyperresponsiveness (excessive airway constriction by normal triggers) [1]. Management of asthma requires long-term treatment to achieve well-controlled symptoms and prevent the risk of exacerbation in future. Inhaled corticosteroid (ICS) is the mainstay therapy of asthma with strong evidences [2]. Nonetheless it is still the existence of gap in knowledge “what is the most appropriate dose of ICS to treat asthmatic patient?”. 


    Published on: Aug 19, 2020 Pages: 13-15

    Full Text PDF Full Text HTML DOI: 10.17352/oja.000013
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on OJA